Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2015

Open Access 01-12-2015 | Meeting abstract

Correlation of execution time of the walking test between force platform and BESTest in diabetic individuals

Authors: Nathalia Cristina de Souza Borges, Ariane Hidalgo Mansano Pletsch, Fernanda Maria Ferreira da Cruz, Natalia Akemi Terada, Duany Maria Villar, Ana Laura Franzini Sutilo, Rinaldo Roberto de Jesus Guirro

Published in: Diabetology & Metabolic Syndrome | Special Issue 1/2015

Login to get access

Excerpt

Type-2 diabetes mellitus is considered a great problem of public health, resulting in complications such as deficits in functional performance of the lower limbs and falls consequently, which can interfere with the balance maintenance. …
Metadata
Title
Correlation of execution time of the walking test between force platform and BESTest in diabetic individuals
Authors
Nathalia Cristina de Souza Borges
Ariane Hidalgo Mansano Pletsch
Fernanda Maria Ferreira da Cruz
Natalia Akemi Terada
Duany Maria Villar
Ana Laura Franzini Sutilo
Rinaldo Roberto de Jesus Guirro
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue Special Issue 1/2015
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-7-S1-A243

Other articles of this Special Issue 1/2015

Diabetology & Metabolic Syndrome 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine